Applied DNA Sciences APDN

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.01 (+5.32%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Applied DNA Sciences (APDN)
    Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.1314

    • Market Cap

      $7.25 Million

    • Price-Earnings Ratio

      -0.03

    • Total Outstanding Shares

      55.19 Million Shares

    • Total Employees

      48

    • Dividend

      No dividend

    • IPO Date

      October 31, 2001

    • SIC Description

      Services-testing Laboratories

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      50 health sciences drive, Stony brook, NY, 11790

    • Homepage

      https://www.adnas.com

    Historical Stock Splits

    If you bought 48,000 shares of APDN before October 29, 2014, you'd have 1 share today.
    Execution DateSplit Amount
    April 25, 20241-for-20 (Reverse Split)
    November 1, 20191-for-40 (Reverse Split)
    October 29, 20141-for-60 (Reverse Split)

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow, Continuing$2.14 Million
    Net Cash Flow From Investing Activities, Continuing$-4.32 Million
    Net Cash Flow$2.14 Million
    Net Cash Flow From Operating Activities, Continuing$-13.28 Million
    Net Cash Flow From Investing Activities$-4.32 Million
    Net Cash Flow From Financing Activities$19.74 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Diluted Average Shares$38.54 Million
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$14.91 Million
    Basic Average Shares$38.54 Million
    Operating Expenses$14.67 Million
    Gross Profit$1.47 Million
    Net Income/Loss Attributable To Parent$-8.53 Million

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss$-8.63 Million
    Comprehensive Income/Loss Attributable To Parent$-8.63 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Other Comprehensive Income/Loss$0

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Intangible Assets$2.70 Million
    Other Current Assets$10.81 Million
    Liabilities$3.42 Million
    Current Liabilities$2.39 Million
    Inventory$468,580
    Noncurrent Assets$4.69 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about APDN from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.